3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Withdrawn
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
111
Carcinoma, Non-Small-Cell Lung
102
Prostatic Neoplasms
66
Multiple Myeloma
64
Neoplasm Metastasis
63
Colorectal Neoplasms
63
Neoplasms
59
Lung Neoplasms
51
Leukemia, Myeloid, Acute
41
Carcinoma, Hepatocellular
41
Recurrence
40
Lymphoma
40
Leukemia, Lymphocytic, Chronic, B-Cell
36
Pancreatic Neoplasms
34
Melanoma
34
Head and Neck Neoplasms
26
Glioblastoma
26
Rectal Neoplasms
25
Ovarian Neoplasms
25
Lymphoma, Large B-Cell, Diffuse
25
Leukemia
24
Brain Neoplasms
24
Squamous Cell Carcinoma of Head and Neck
23
Hematologic Neoplasms
23
Carcinoma, Renal Cell
23
Precursor Cell Lymphoblastic Leukemia-Lymphoma
22
Myelodysplastic Syndromes
20
Colonic Neoplasms
20
Triple Negative Breast Neoplasms
19
Lymphoma, Non-Hodgkin
19
Interventions
brigimadlin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Withdrawn
×
Tertiary Lymphoid Structures
×
Clear all
NCT06084689
2025-09-02
EMPIRE
Institut Bergonié
Phase 2
Withdrawn